Literature DB >> 17085001

Increased production of inflammatory cytokines in mild cognitive impairment.

Shino Magaki1, Claudius Mueller, Cindy Dickson, Wolff Kirsch.   

Abstract

Recent studies indicate that chronic inflammation plays a pathogenic role in both the central nervous system (CNS) and periphery in Alzheimer's disease (AD). We have screened for cytokines differentially produced by peripheral blood mononuclear cells (PBMCs) isolated from subjects with mild cognitive impairment (MCI) and mild AD subjects who had progressed from MCI using a commercially available cytokine array. Following determination of expressed cytokines, we quantified levels of the proinflammatory cytokines TNF-alpha, IL-6, and IL-8, and the anti-inflammatory cytokine IL-10 using flow cytometry. We have found a significant increase in the levels of IL-6, IL-8, and IL-10 produced by PBMCs stimulated for 24 h with phytohemagglutinin (PHA) in MCI subjects compared to healthy elderly controls. However, in PBMCs stimulated for 48 h with lipopolysaccharide (LPS), lower TNF-alpha/IL-10, IL-6/IL-10, and IL-8/IL-10 ratios were seen in MCI subjects. There were no differences in plasma levels of IL-8 between aged controls, MCI, and mild AD, and the levels of circulating IL-6 and IL-10 were below detection limits. Our data indicate that changes in cytokine production by PBMCs may be detected early in MCI, and an alteration of the immune response may precede clinical AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085001      PMCID: PMC1868444          DOI: 10.1016/j.exger.2006.09.015

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  45 in total

1.  Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.

Authors:  J T Rogers; L M Leiter; J McPhee; C M Cahill; S S Zhan; H Potter; L N Nilsson
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  IL-8 enhancement of amyloid-beta (Abeta 1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia.

Authors:  Sonia Franciosi; Hyun B Choi; Seung U Kim; James G McLarnon
Journal:  J Neuroimmunol       Date:  2004-11-26       Impact factor: 3.478

3.  Differential involvement of central and peripheral norepinephrine in the central lipopolysaccharide-induced interleukin-6 responses in mice.

Authors:  D K Song; Y B Im; J S Jung; H W Suh; S O Huh; S W Park; M B Wie; Y H Kim
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

4.  Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.

Authors:  V R Lombardi; M García; L Rey; R Cacabelos
Journal:  J Neuroimmunol       Date:  1999-06-01       Impact factor: 3.478

5.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies.

Authors:  P L McGeer; M Schulzer; E G McGeer
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

Review 6.  New insights into the molecular mechanism of interleukin-10-mediated immunosuppression.

Authors:  Gerald Grütz
Journal:  J Leukoc Biol       Date:  2004-11-02       Impact factor: 4.962

7.  Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35].

Authors:  L Meda; P Baron; E Prat; E Scarpini; G Scarlato; M A Cassatella; F Rossi
Journal:  J Neuroimmunol       Date:  1999-01-01       Impact factor: 3.478

8.  A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

Authors:  A Papassotiropoulos; M Bagli; F Jessen; T A Bayer; W Maier; M L Rao; R Heun
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

Review 9.  The importance of inflammatory mechanisms in Alzheimer disease.

Authors:  E G McGeer; P L McGeer
Journal:  Exp Gerontol       Date:  1998-08       Impact factor: 4.032

10.  Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide.

Authors:  P E Gottschall; G Komaki; A Arimura
Journal:  Neuroendocrinology       Date:  1992-12       Impact factor: 4.914

View more
  44 in total

1.  Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.

Authors:  Daniel C Parker; Michelle M Mielke; Qilu Yu; Paul B Rosenberg; Alka Jain; Constantine G Lyketsos; Neal S Fedarko; Esther S Oh
Journal:  Int J Geriatr Psychiatry       Date:  2012-04-27       Impact factor: 3.485

2.  The role of macrophage migration inhibitory factor in Alzheimer's disease.

Authors:  Michael Bacher; Oliver Deuster; Bayan Aljabari; Rupert Egensperger; Frauke Neff; Frank Jessen; Julius Popp; Carmen Noelker; Jens Peter Reese; Yousef Al-Abed; Richard Dodel
Journal:  Mol Med       Date:  2010-02-28       Impact factor: 6.354

3.  Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.

Authors:  Kaori Morimoto; Juri Horio; Haruhisa Satoh; Lucia Sue; Thomas Beach; Seizaburo Arita; Ikuo Tooyama; Yoshihiro Konishi
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Relation between aerobic fitness and brain structures in amnestic mild cognitive impairment elderly.

Authors:  Camila Vieira Ligo Teixeira; Thiago J R Rezende; Marina Weiler; Mateus H Nogueira; Brunno M Campos; Luiz F L Pegoraro; Jessica E Vicentini; Gabriela Scriptore; Fernando Cendes; Marcio L F Balthazar
Journal:  Age (Dordr)       Date:  2016-04-23

Review 5.  Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

Authors:  Subbiah Pugazhenthi; Limei Qin; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-05-06       Impact factor: 5.187

Review 6.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 7.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

8.  Cognitive dysfunction with aging and the role of inflammation.

Authors:  Arthur A Simen; Kelly A Bordner; Mark P Martin; Lawrence A Moy; Lisa C Barry
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

Review 9.  Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.

Authors:  Chun Shi; Jun Liu; Fengming Wu; David T Yew
Journal:  Int J Mol Sci       Date:  2010-01-08       Impact factor: 5.923

10.  Daily exercise improves memory, stimulates hippocampal neurogenesis and modulates immune and neuroimmune cytokines in aging rats.

Authors:  Rachel B Speisman; Ashok Kumar; Asha Rani; Thomas C Foster; Brandi K Ormerod
Journal:  Brain Behav Immun       Date:  2012-10-16       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.